Position in AZN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,180,763
New position
Shares Held
6,227
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#630
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clear Creek Financial Management, LLC holds $18,746,377 across 11 Drug Manufacturers - General names. AZN ranks #8 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,281 | $5,134,760 | |
| 2 | JNJ |
Johnson & Johnson
|
10,174 | $2,583,890 | |
| 3 | ABBV |
AbbVie Inc.
|
10,246 | $2,578,303 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
15,209 | $1,921,505 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,408 | $1,465,928 | |
| 6 | NVO |
Novo Nordisk A S
|
28,506 | $1,366,577 | |
| 7 | NVS |
Novartis AG
|
8,250 | $1,292,940 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
6,227 | $1,180,763 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,180,763 | 6,227 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||